新型二氢呋喃类化合物的合成及抑制血小板聚集活性研究

钟涵宇; 张一凯; 张敬一; 李科; 钟涵宇; 张一凯; 张敬一; 李科

doi:10.3969/j.issn.1006-0111.2014.02.007

[1]

杨曦明, 范聪, 李慧萍, 等. 白树花多糖硫酸酯的抗凝血活性研究[J]. 中国实验诊断学, 2010, 14 (7):1031.

[2]

Gardell SJ, Sanderson PE. Novel anticoagulants based on direct inhibition of thrombin and factor Xa[J]. Coron Artery Dis, 1998, 9 (2-3):75.

[3]

赵东明, 刘超美. 6-取代乙酰哌嗪苯基二氢哒嗪酮类化合物的合成及其抑制血小板聚集的作用[J]. 第二军医大学学报, 2003, 24 (5):510.

[4]

覃军, 王祥志, 刘毅敏. 6-(4-取代苯基)-5-甲基-4,5-二氢-3(2H)哒嗪酮类化合物的合成及其抑制血小板聚集的作用[J]. 化学研究与应用, 2006, 18 (9):1088.

[5]

周大铮, 易杨华, 毛士龙, 等. 香榧假种皮中的木脂素成分[J]. 药学学报, 2004, 39 (4):269.

[6]

Yang GM, Liu LM, Xu J. Effects of MCI-154 on vascular reactivity and its mechanisms after hemorrhagic shock in rats[J]. J Cardiov, 2006, 47 (6):751.

[7]

Kitada Y, Narimatsu A, Matsumura N, et al. Increase in Ca²⁺ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles[J]. J Pharmacol Exp Ther, 1987, 243 (2):633.

[8]

Okafor C, Liao R, Perreault-Micale C, et al. Mg²⁺-ATPase and Ca²⁺ activated myosin ATPase activity in ventricular myofibrils from non-failing and diseased human hearts-effects of calcium sensitizing agents MCI-154, DPI 201-106, and caffeine[J]. Mol Cell Biochem, 2003, 245 (1-2):77.